Cryo-Cell International (FRA:ZCY) EPS without NRI: €0.17 (TTM As of May. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:ZCY Cryo-Cell International Inc FRA:ZCY
67 GF Score
Price €2.84
GF Value €4.39
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Cryo-Cell International EPS without NRI?

Cryo-Cell International FRA:ZCY +1.43% 67 EPS without NRI is €0.17 as of May. 2026. GuruFocus rates FRA:ZCY with a GF Score™ of 67/100 and a GF Value™ of €4.39 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 510 Healthcare Providers & Services companies, Cryo-Cell International ranks worse than 77.65% on this metric.

Cryo-Cell International's earnings per share without non-recurring items for the three months ended in May. 2026 was €0.06. Its earnings per share without non-recurring items for the trailing twelve months (TTM) ended in May. 2026 was €0.17.

During the past 3 years, the average earnings per share (NRI) Growth Rate was -11.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using Earnings per share without Non-Recurring Items (NRI) data.

The historical rank and industry rank for Cryo-Cell International's EPS without NRI or its related term are showing as below:

FRA:ZCY' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -55.8   Med: -1.8   Max: 79.4
Current: -11.1

During the past 13 years, Cryo-Cell International's highest 3-Year average Earnings Per Share (NRI) Growth Rate was 79.40% per year. The lowest was -55.80% per year. And the median was -1.80% per year.

FRA:ZCY's 3-Year EPS without NRI Growth Rate is ranked worse than
77.65% of 510 companies
in the Healthcare Providers & Services industry
Industry Median: 11.65 vs FRA:ZCY: -11.10

Cryo-Cell International's EPS (Diluted) for the three months ended in May. 2026 was €0.06. Its EPS (Diluted) for the trailing twelve months (TTM) ended in May. 2026 was €-0.26.

Cryo-Cell International's EPS (Basic) for the three months ended in May. 2026 was €0.06. Its EPS (Basic) for the trailing twelve months (TTM) ended in May. 2026 was €-0.26.


Cryo-Cell International  (FRA:ZCY) EPS without NRI Explanation

EPS without NRI removes onetime and unusual items from EPS, to provide investors with a more accurate measure of the company’s true earnings. The earnings are adjusted for items that are irregular or unusual in nature, and/or are non-recurring. This is calculated using Net Income (Continuing Operations) plus/minus any tax affected unusual Items and Goodwill Impairments/Write Offs. This can be used to fairly measure a company's profitability.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Cryo-Cell International EPS without NRI Related Terms


Cryo-Cell International EPS without NRI Historical Data

* Premium members only.

The historical data trend for Cryo-Cell International's EPS without NRI can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cryo-Cell International EPS without NRI Chart

Cryo-Cell International Annual Data
Trend Nov16 Nov17 Nov18 Nov19 Nov20 Nov21 Nov22 Nov23 Nov24 Nov25
EPS without NRI
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.25 0.29 0.18 -0.03 0.18

Cryo-Cell International Quarterly Data
Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25 May25 Aug25 Nov25 Feb26 May26
EPS without NRI Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.06 0.09 -0.00 0.03 0.06

FRA:ZCY vs CCM, CDIX, EHSI: EPS without NRI Comparison

For the Medical Care Facilities subindustry, Cryo-Cell International's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cryo-Cell International PE Ratio without NRI vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Cryo-Cell International's PE Ratio without NRI distribution charts can be found below:

* The bar in red indicates where Cryo-Cell International's PE Ratio without NRI falls into.


FRA:ZCY
67GF Score
Cryo-Cell International Inc FRA:ZCY
EPS without NRI is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cryo-Cell International EPS without NRI Calculation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock.

EPS without NRI for the trailing twelve months (TTM) ended in May. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.17

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS without NRI →
What does a EPS without NRI of €0.17 mean?
Cryo-Cell International (FRA:ZCY) has a EPS without NRI of €0.17 as of May. 2026. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Cryo-Cell International and its competitors. According to the industry distribution chart, Cryo-Cell International ranks #396 out of 510 companies in the Healthcare Providers & Services industry, placing it in the top 77.6%.
Is Cryo-Cell International's EPS without NRI too high?
Cryo-Cell International's current EPS without NRI is €0.17. Based on the distribution chart, Cryo-Cell International ranks #396 out of 510 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Cryo-Cell International has a GF Score™ of 67/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Cryo-Cell International's EPS without NRI compare to CCM and CDIX?
According to the Healthcare Providers & Services industry distribution chart, Cryo-Cell International ranks #396 out of 510 companies for EPS without NRI. This places Cryo-Cell International in the lower half of its industry. The industry median EPS without NRI is 11.65. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS without NRI for a Healthcare Providers & Services company?
The median EPS without NRI among Healthcare Providers & Services companies is 11.65, based on 510 companies in the industry. Companies in the top quartile (top 25%) have a EPS without NRI significantly above this median, while those in the bottom quartile fall well below. However, EPS without NRI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS without NRI mean?
A high EPS without NRI can signal that a stock is expensive relative to its fundamentals. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Cryo-Cell International and its competitors. For the Healthcare Providers & Services industry, the median EPS without NRI is 11.65 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cryo-Cell International's current EPS without NRI is €0.17. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cryo-Cell International stock overvalued right now?
Based on GuruFocus' analysis, Cryo-Cell International (FRA:ZCY) is currently considered Possible Value Trap. The stock's GF Value™ is €4.39, compared to a current price of €2.84 — trading 35.3% below its estimated fair value. The current EPS without NRI is €0.17. Cryo-Cell International's overall GF Score™ is 67/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS without NRI calculated?
EPS without NRI is calculated from a company's financial statements. For Cryo-Cell International (FRA:ZCY), the current EPS without NRI is €0.17 as of May. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Cryo-Cell International (FRA:ZCY) Overvalued in 2026?

Based on GuruFocus' analysis, Cryo-Cell International stock appears to be undervalued. The current stock price of €2.84 is trading 35.3% below its estimated GF Value™ of €4.39. GuruFocus considers Cryo-Cell International to be Possible Value Trap.

Key valuation signals for FRA:ZCY:

  • EPS without NRI: €0.17
  • GF Value™: €4.39 vs. price of €2.84 (35.3% below fair value)
  • GF Score™: 67/100 with 4 warning signs

No single metric tells the full story. See the FRA:ZCY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Cryo-Cell International Business Description

Other Exchanges CCEL:USA
Address 700 Brooker Creek Boulevard, Suite 1800, Oldsmar, FL, USA, 34677
Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from Cellular processing and Cryogenic storage and it derives revenue from processing and testing fees and Storage segment.
67GF Score

Get the complete analysis for FRA:ZCY

EPS without NRI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€2.84
Price
€4.39
GF Value